New Genetics and Society

Papers
(The median citation count of New Genetics and Society is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Governance through scientism: Taiwan Biobank and public controversy12
The commercial dynamics of direct-to-consumer genome testing and law enforcement cooperation11
Human heritable genome editing and its governance: views of scientists and governance professionals10
Capitalization and the production of value at the nexus of academia and industry: the case of a microbiome startup7
The matrix of stem cell research: an approach to rethinking science in society6
Public concerns about direct-to-consumer DNA test kits: the evidence from survey and social media data6
The unexpected and unanticipated announcement of the “world’s first” gene edited babies: breaching, repairing and strengthening community boundaries6
Donors: curious connections in donor conception Donors: curious connections in donor conception , by P. Nordqvist and L. Gilman, Bingley, Emerald Group Publishing, 2022,6
Safe and purposeful genome editing under harmonized regulation for responsible use: views of research experts5
Consensus too soon: judges’ and lawyers’ views on genetic information use5
Healthcare activism: markets, morals, and the collective good Healthcare activism: markets, morals, and the collective good , edited by Susi Geiger, Oxford, Oxford Unive5
Laboring bodies and the quantified self4
Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations4
Freezing fertility: oocyte cryopreservation and the gender politics of aging3
Commoning contingent resources: constructing an Australian stem cell registry3
“We are all cousins.” Belgian ancestry and genomic testing in a close-knit community in Northeastern Wisconsin3
“It’s personalized, but it’s still bucket based”: the promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial3
Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns2
Toxic disruptions: polycystic ovary syndrome in urban India2
Building the airplane while flying it: tracking the transformation of novel sequencing practices into clinical services2
Mitochondrial replacement in the English-language print media: continuity and change in metaphors and social representations2
Recoding the gift relationship: views on introducing genomic testing to blood donation2
Siloed discourses: a year-long study of twitter engagement on the use of CRISPR in food and agriculture2
“I am happy to be alive, but I prefer to have children without my chronic disease”: chronically ill persons’ views on reproduction and genetic testing for their own condition2
Acid Revival: The psychedelic renaissance and the quest for medical legitimacy2
Goffman against DNA: genetic stigma and the use of genetic ancestry tests by white nationalists2
Constructing maternal responsibility: narratives of “motherly love” and maternal blame in epigenetics research1
Conviction: the making and unmaking of the violent brain1
“Donating with eyes shut”: attitudes regarding DNA donation to a large-scale biobank in Israel1
Genetic subjectivities of prospective fathers: men’s attitudes toward epigenetics1
Bio-imperialism. Disease, terror and the construction of national fragility1
A History of Genomics Across Species, Communities and Projects1
How we get Mendel wrong, and why it matters: challenging the narrative of Mendelian genetics1
The challenge of recruiting diverse populations into health research: an embedded social science perspective1
Capitalizing a cure: how finance controls the price and value of medicines1
1.4566760063171